Cargando…
Recurrent SARS-CoV-2 infection resulting in acute respiratory distress syndrome and development of pulmonary hypertension: A case report
The COVID-19 pandemic has affected millions of individuals worldwide. In the United States, the rapid transmission of cases has created challenges for healthcare systems across the country. We report a case of a patient who fully recovered from COVID-19 with intermittent negative RT-PCR testing and...
Autores principales: | Salcin, Sameena, Fontem, Franklin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718582/ https://www.ncbi.nlm.nih.gov/pubmed/33312856 http://dx.doi.org/10.1016/j.rmcr.2020.101314 |
Ejemplares similares
-
Defibrotide Therapy for Sars CoV2 Acute Respiratory Distress Syndrome
por: Yanik, Gregory A, et al.
Publicado: (2021) -
SARS-CoV-2–induced Acute Respiratory Distress Syndrome: Pulmonary Mechanics and Gas-Exchange Abnormalities
por: Barbeta, Enric, et al.
Publicado: (2020) -
Neurophysiological Aspects in SARS-CoV-2–Induced Acute Respiratory Distress Syndrome
por: Vecchio, Eleonora, et al.
Publicado: (2022) -
Pulmonary endothelial NEDD9 and the prothrombotic pathophenotype of acute respiratory distress syndrome due to SARS‐CoV‐2 infection
por: Alba, George A., et al.
Publicado: (2022) -
Ruxolitinib for the treatment of SARS-CoV-2 induced acute respiratory distress syndrome (ARDS)
por: Neubauer, Andreas, et al.
Publicado: (2020)